Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
SolasCure has raised €30M across 2 funding rounds from 10 investors, most recently a Series B round in Mar 2023. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2023-03-27 | Series B | €12M | BRAIN Biotech,EVA Pharma,Jonathan Milner,Seneca Partners,Wealth Club | View deal → |
| 2021-08-10 | Series A | €18M | Bionova Capital,Development Bank of Wales,Dr Jonathan Milner,EVA Pharma,François Fournier,RAIN Biotech AG+1 more | View deal → |
